3-iodobenzylguanidine has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barzon, L; Boscaro, M; Fallo, F; Gregianin, M; Macrì, C; Scaroni, C; Sonino, N | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Topics: 17-alpha-Hydroxyprogesterone; 3-Iodobenzylguanidine; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Biopsy, Needle; Dehydroepiandrosterone Sulfate; Dexamethasone; Diagnosis, Differential; Female; Hormones; Humans; Hydrocortisone; Hyperaldosteronism; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Postmenopause; Premenopause; Radiopharmaceuticals; Renin; Retrospective Studies; Selenium Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |